BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23726930)

  • 1. [Antisynthetase syndrome and lung carcinoma: a fortuitous association?].
    Courties A; Lidove O; Maisonobe T; Rigolet A; Hermet A; Girard P; Ziza JM
    Rev Med Interne; 2014 Apr; 35(4):271-3. PubMed ID: 23726930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squamous cell carcinoma of the lung associated with anti-Jo1 antisynthetase syndrome: a case report and review of the literature.
    Boleto G; Perotin JM; Eschard JP; Salmon JH
    Rheumatol Int; 2017 Jul; 37(7):1203-1206. PubMed ID: 28447208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome.
    Marie I; Josse S; Decaux O; Dominique S; Diot E; Landron C; Roblot P; Jouneau S; Hatron PY; Tiev KP; Vittecoq O; Noel D; Mouthon L; Menard JF; Jouen F
    Autoimmun Rev; 2012 Aug; 11(10):739-45. PubMed ID: 22326685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies.
    Shi J; Li S; Yang H; Zhang Y; Peng Q; Lu X; Wang G
    J Rheumatol; 2017 Jul; 44(7):1051-1057. PubMed ID: 28461650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute interstitial lung disease revealing antisynthetase syndrome].
    Bizien N; Renault A; Boles JM; Delluc A
    Rev Pneumol Clin; 2011 Dec; 67(6):367-70. PubMed ID: 22137282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcoidosis in Patients with Antisynthetase Syndrome: Presentation and Outcome.
    Couture P; Brillet PY; Varin S; Le Goff B; Meyer A; Sibilia J; Jouneau S; Valeyre D; Hervier B; Uzunhan Y
    J Rheumatol; 2018 Aug; 45(9):1296-1300. PubMed ID: 29961694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type.
    Johnson C; Connors GR; Oaks J; Han S; Truong A; Richardson B; Lechtzin N; Mammen AL; Casciola-Rosen L; Christopher-Stine L; Danoff SK
    Respir Med; 2014 Oct; 108(10):1542-8. PubMed ID: 25269710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between anti-PL7 antibodies and increased fibrotic component in patients with antisynthetase syndrome and interstitial lung disease: a cross-sectional study.
    Rivero-Gallegos D; Mejía M; Rocha-González HI; Huerta-Cruz JC; Falfán-Valencia R; Ramos-Martínez E; Mateos-Toledo HN; Castillo-López MF; Rodríguez-Torres YK; Lira-Boussart V; Rojas-Serrano J
    Clin Rheumatol; 2024 Jun; 43(6):1971-1978. PubMed ID: 38642252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Jo-1 myositis and the antiphospholipid syndrome showing right ventricular thrombus: a novel overlap syndrome with atypical presentation.
    Wang CH; Wang NC; Lin TY; Chen CH
    Mod Rheumatol; 2014 Sep; 24(5):865-8. PubMed ID: 24517557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab in the Treatment of Jo1 Antibody-associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response.
    Bauhammer J; Blank N; Max R; Lorenz HM; Wagner U; Krause D; Fiehn C
    J Rheumatol; 2016 Aug; 43(8):1566-74. PubMed ID: 27252419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antisynthetase syndrome - a case report].
    Prus V; Bedeković D; Milas-Ahić J; Visević R; Segec B; Jukić Z; Perić L
    Reumatizam; 2013; 60(1):25-8. PubMed ID: 24003680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antisynthetase syndrome with pulmonary hypertension: 4 original observations].
    Lecomte R; Perrin F; Journeau L; Espitia O; Piriou N; Horeau-Langlard D; Néel A; Masseau A; Hamidou M; Agard C
    Rev Med Interne; 2015 Dec; 36(12):794-9. PubMed ID: 25895991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanics hands in patients with antisynthetase syndrome: 25 cases.
    Gusdorf L; Morruzzi C; Goetz J; Lipsker D; Sibilia J; Cribier B
    Ann Dermatol Venereol; 2019 Jan; 146(1):19-25. PubMed ID: 30595338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The shades of anti-Jo1 positive antisynthetase syndrome in a Hungarian cohort].
    Szabó K; Nagy-Vincze M; Bodoki L; Hodosi K; Dankó K; Griger Z
    Orv Hetil; 2016 Apr; 157(15):575-83. PubMed ID: 27039996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use.
    Stanciu R; Guiguet M; Musset L; Touitou D; Beigelman C; Rigolet A; Costedoat-Chalumeau N; Allenbach Y; Hervier B; Dubourg O; Maisonobe T; Charuel JL; Behin A; Herson S; Amoura Z; Grenier P; Benveniste O
    J Rheumatol; 2012 Sep; 39(9):1835-9. PubMed ID: 22859355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of autoantibody screening in patients with autoimmune myositis.
    Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
    Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease.
    La Corte R; Lo Mo Naco A; Locaputo A; Dolzani F; Trotta F
    Autoimmunity; 2006 May; 39(3):249-53. PubMed ID: 16769659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Negative Antinuclear Antibody Does Not Indicate Autoantibody Negativity in Myositis: Role of Anticytoplasmic Antibody as a Screening Test for Antisynthetase Syndrome.
    Aggarwal R; Dhillon N; Fertig N; Koontz D; Qi Z; Oddis CV
    J Rheumatol; 2017 Feb; 44(2):223-229. PubMed ID: 27909085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated myositis in the presence of anti-Jo1 autoantibodies and the antisynthetase syndrome.
    Legault D; McDermott J; Crous-Tsanaclis AM; Boire G
    J Rheumatol; 2008 Jan; 35(1):169-71. PubMed ID: 18176990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity.
    Hervier B; Devilliers H; Stanciu R; Meyer A; Uzunhan Y; Masseau A; Dubucquoi S; Hatron PY; Musset L; Wallaert B; Nunes H; Maisonobe T; Olsson NO; Adoue D; Arlet P; Sibilia J; Guiguet M; Lauque D; Amoura Z; Hachulla E; Hamidou M; Benveniste O
    Autoimmun Rev; 2012 Dec; 12(2):210-7. PubMed ID: 22771754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.